Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Milloy N; Adelphi Real World, Adelphi Mill, Grimshaw Lane, Bollington, Macclesfield, Cheshire, United Kingdom.; Kirker M
Subjects: Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/drug therapy ; Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/Carcinoma, Transitional Cell*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use
-
Source:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Feb; Vol. 22 (1), pp. e136-e147.e1. Date of Electronic Publication: 2023 Oct 02.Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Matasar M; Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New Brunswick, NJ.; Bartlett NL
Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Lymphoma, B-Cell*/Lymphoma, B-Cell*/Lymphoma, B-Cell*/pathology ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/pathology
-
Source:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Apr; Vol. 24 (4), pp. 240-253. Date of Electronic Publication: 2023 Dec 12.Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Vokinger KN; Institute of Law, University of Zurich, Zurich, Switzerland .; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use; United States
-
Source:
BMJ (Clinical research ed.) [BMJ] 2023 Jul 05; Vol. 382, pp. e074166. Date of Electronic Publication: 2023 Jul 05.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Ruggiero R; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine, Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/adverse effects; Humans
-
Source:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2023 May; Vol. 16 (5), pp. 423-434. Date of Electronic Publication: 2023 May 11.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Knoll L; Department of Pharmacy, University Medical Center of the Johannes Gutenberg University, Mainz, Rheinland-Pfalz, Germany .; Kraemer I
Subjects: Carmustine* ; Antineoplastic Agents*; Temperature
-
Source:
European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2023 Jan; Vol. 30 (1), pp. 11-16. Date of Electronic Publication: 2021 May 05.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited Medium: Print ISSN:
Record details
